MabThera International Trial - MInT

This is a listing of clinical institutions open to accept patients for the randomised intergroup trial of first line treatment for patients with diffuse large B-cell lymphoma with a CHOP-like chemotherapy regimen with or without the anti-CD20 antibody rituximab (Mabthera).

If you are a patient, please contact your local doctor for further advise.

Use "CTRL-F" to find information on this site!

Fatal error: Call to undefined function ocilogon() in /opt/wcm/website/mint_prod/hospitals_public.html on line 65

Country	Klinik